SCHEMBL3606907

SCHEMBL3606907

O=C(O)c1cccc(-c2cc(-c3nnn[nH]3)c(-c3cccc(C(=O)O)c3)s2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
HSD17B1 P14061 2/20 0.43
CD74 P04233 1/20 0.42
MIF P14174 1/20 0.42
HSD17B2 P37059 1/20 0.42
KMO O15229 2/20 0.40
MAP2K4 P45985 2/20 0.40
MAPK1 P28482 1/20 0.40
MAPKAPK3 Q16644 1/20 0.40
MAPK6 Q16659 1/20 0.40
KDM4E B2RXH2 1/20 0.39
NPC1 O15118 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
RXRA P19793 2/20 0.37
RXRB P28702 2/20 0.37
IKBKB O14920 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3596461 0.89 HSD17B1 (0.41) HSD17B1HSD17B2MAP2K4MAPK1IKBKB
SCHEMBL3607451 0.86 ESR1 (0.41) HDAC1HDAC6HSD17B1MAP2K4MAPK1
SCHEMBL3613513 0.83 ALDH1A1 (0.41) KDM4ENPC1ALDH1A1HPGDRAB9A
SCHEMBL3596099 0.82 HSD17B1 (0.64) HSD17B1HSD17B2
SCHEMBL939586 0.81 CD74 (0.53) CD74MIFKMOMAP2K4MAPK1
SCHEMBL30425732 0.81 CD74 (0.53) CD74MIFKMOMAP2K4MAPK1
SCHEMBL3595152 0.78 PRF1 (0.42) MAP2K4MAPK1MAPKAPK3MAPK6
SCHEMBL3601027 0.77 HDAC6 (0.41) HDAC6HSD17B1HSD17B2MAPK1KDM4E
SCHEMBL12497225 0.76 ALDH1A1 (0.41) KDM4ENPC1ALDH1A1HPGDRAB9A
SCHEMBL3608422 0.75 NPSR1 (0.43) HDAC1HDAC6HSD17B1HSD17B2KMO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8835476-B2 Synthesis of novel antimicrobials WU FAN (CA) 2014-09-16 US disclosed
US-20100076028-A1 Design and Synthesis of Novel Antimicrobials WU FAN 2010-03-25 US disclosed
WO-2006092059-A1 DESIGN AND SYNTHESIS OF NOVEL ANTIMICROBIALS WU FAN (CA) 2006-09-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100076028-A1 Design and Synthesis of Novel Antimicrobials MLX, LPXN, TPX2 HDAC1 3698/4885HDAC6 4748/4885HSD17B1 3041/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.